Scout Investments »

Halozyme Therapeutics shares owned by Scout Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Scout Investments from 13F filings

Historical chart of Scout Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Scout Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Scout Investments

Quarter filed Position value Share count Share price at filing
2023-09-30 $10M 266k 37.69
2023-06-30 $12M 273k 43.75
2023-03-31 $11M 281k 38.19
2022-12-31 $16M 285k 56.90
2022-09-30 $12M 300k 39.54
2022-06-30 $13M 299k 44.00
2022-03-31 $12M 292k 39.88
2021-12-31 $12M 292k 40.21
2021-09-30 $12M 299k 40.68
2021-06-30 $14M 311k 45.41
2021-03-31 $14M 337k 41.69
2020-12-31 $13M 303k 42.71
2020-09-30 $7.7M 294k 26.28
2020-06-30 $6.4M 239k 26.81